Elevance Health Inc. (ELV)
| Market Cap | 124.56B |
| Revenue (ttm) | 171.75B |
| Net Income (ttm) | 6.24B |
| Shares Out | 232.42M |
| EPS (ttm) | 26.49 |
| PE Ratio | 20.23 |
| Forward PE | 13.85 |
| Dividend | $6.52 (1.22%) |
| Ex-Dividend Date | Jun 10, 2024 |
| Volume | 1,035,205 |
| Open | 534.40 |
| Previous Close | 534.55 |
| Day's Range | 530.90 - 538.40 |
| 52-Week Range | 412.00 - 550.34 |
| Beta | 0.83 |
| Analysts | Strong Buy |
| Price Target | 606.07 (+13.09%) |
| Earnings Date | Jul 17, 2024 |
About ELV
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates i... [Read more]
Financial Performance
In 2023, ELV's revenue was $171.34 billion, an increase of 9.42% compared to the previous year's $156.60 billion. Earnings were $5.99 billion, an increase of 1.58%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for ELV stock is "Strong Buy." The 12-month stock price forecast is $606.07, which is an increase of 13.09% from the latest price.
News
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley has initiated coverage on Elevance Health Inc ELV, an American health insurance provider formerly Anthem Inc, citing compelling risk-reward.
Elevance exec says Medicaid attrition has changed mix of members
Elevance Health executive Peter Haytaian said on Wednesday that a decrease in the number of people eligible for its Medicaid plans this year, as well as changes the company made in where it operates t...
Elevance Health Foundation Exceeds $30 Million Milestone With Substance Use Disorder Programs Through Third Phase of Grants
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces the expansion of its substance use disorder (SUD) grants through an additional $13....
Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Flor...
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Shares of U.S. health insurers fell on Wednesday after UnitedHealth Group cited a near-term disturbance around reimbursement rates for Medicaid due to ongoing program-wide enrollment hurdles that bega...
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc.'s New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned the Long-Term Issue Credit Ratings of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $600 ...
Elevance Health Foundation Announces $10 Million to Launch New Impact Investing Initiative
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces a $10 million commitment to launch a new impact investing program to create positiv...
Elevance Health Announces Appearance at Bernstein's 40th Annual Strategic Decisions Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on...
Elevance Health Stock Rises After Earnings Top Expectations, Guidance Boosted
Shares of Elevance Health (ELV) rose to their highest level since late 2022 on Thursday as the health insurance provider posted better-than-expected results and raised its guidance amid lower costs.
Elevance Health's quarterly profit tops estimates to offset a revenue shortfall
Elevance Health Inc.'s stock rose 4.7% on Thursday, after the health insurer posted better-than-expected profit for the first quarter and raised a full-year guidance metric, offsetting a revenue short...
Elevance beats first-quarter profit estimates on higher premiums
Elevance Health beat Wall Street estimates for first-quarter profit on Thursday, as higher premiums in its commercial insurance business helped keep medical costs for the insurer in check.
Elevance Health Reports First Quarter 2024 Results
INDIANAPOLIS--(BUSINESS WIRE)---- $ELV #earnings--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2024 results. “First quarter results reflect disciplined execution of our strategic initiativ...
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care del...
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these...
Health care stocks headed for worst day since early November
CNBC's Bertha Coombs reports on what's driving health insurer stocks lower.
Health insurer stocks slide as final Medicare Advantage rates disappoint
The rate adds more pressure on insurers already grappling with high medical costs and uncertainty after the cyberattack on UnitedHealth Group's tech unit.
Elevance Health Foundation Names Professional Basketball Player Kevin Love as Next Elevance Health Champion
INDIANAPOLIS--(BUSINESS WIRE)--The Elevance Health Foundation, the philanthropic arm of Elevance Health Inc., today announces professional basketball player Kevin Love as its latest Elevance Health Ch...
The Standard Closes Acquisition of Life & Disability Business from Elevance Health, Enters Distribution Partnership
PORTLAND, Ore.--(BUSINESS WIRE)--StanCorp Financial Group, Inc. (“The Standard”) today announced the closing of the acquisition of the Life & Disability business from Elevance Health in accordance wit...
First Medicare Health Plans to Start Paying for Weight-Loss Drug Wegovy
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.
Wegovy will be covered by some insurers, but not for weight loss: report
Some large health insurers in the U.S. will start covering Wegovy, which has become a popular anti-obesity drug — but not for those using it to lose weight, according to a report by The Wall Street Jo...
Kroger Announces Plan to Sell Specialty Pharmacy Business to Elevance Health
Grocery-store chain Kroger (KR) is selling its specialty pharmacy business to U.S. health insurer Elevance Health (ELV).
Kroger to Sell Specialty Pharmacy Business to Elevance Health's CarelonRx
Grocery store operator The Kroger Company plans to sell its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health. Kroger has entered into a definitive agreement for the sale, the ...
Kroger to sell specialty pharmacy business to Elevance Health's CarelonRx
Grocer Kroger said on Monday it had entered a definitive agreement for the sale of its specialty pharmacy business to CarelonRx, a unit of U.S. health insurer Elevance Health.
Elevance Health Announces Closing of Paragon Healthcare Acquisition
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible a...